数字诊断技术开发商IDENTIFYSENSORS获得2000万美元融资，用于推进新型数字诊断平台的发展-动脉网

IDENTIFYSENSORS RAISES $20 MILLION TO ADVANCE NEW DIGITAL DIAGNOSTICS PLATFORM

CISION 等信源发布 2025-03-04 04:23



可切换为仅中文







CLEVELAND

克利夫兰

，

March 3, 2025

2025年3月3日

/PRNewswire/ -- IdentifySensors Biologics, a leading developer of digital diagnostic technologies, has raised

/PRNewswire/ -- IdentifySensors生物公司，一家领先的数字诊断技术开发商，已经筹集了

$20 million

2000万美元

to commercialize a software platform using semiconductors that function as rapid biosensors. When connected to a dedicated Bluetooth device, the sensors are intended to rapidly detect targeted gene sequences indicative of infectious diseases and potentially various cancers using a patient sample.

将利用半导体作为快速生物传感器的软件平台商业化。当连接到专用蓝牙设备时，这些传感器旨在通过患者样本快速检测指示传染性疾病和潜在各种癌症的目标基因序列。

This new platform is intended to redefine molecular detection by eliminating reliance on centralized laboratories, while enabling real-time molecular diagnostics at the point-of-need.

这个新平台旨在通过消除对中心实验室的依赖，重新定义分子检测，同时在需要的地方实现分子诊断。

'Current molecular diagnostics are based on decades old technologies that are slow, expensive and require complex laboratories and highly skilled labor to administer,' said IdentifySensors CEO

“目前的分子诊断基于数十年前的技术，这些技术速度慢、成本高，且需要复杂的实验室和高度熟练的人员来进行操作，”IdentifySensors首席执行官表示。

Greg Hummer

格雷格·哈默

. 'This new platform is intended to detect targeted DNA or RNA in minutes through small, simple and inexpensive electronic circuits that interact with Cloud-based algorithms and software.'

“这个新平台旨在通过与基于云的算法和软件交互的小型、简单且廉价的电子电路，在几分钟内检测到目标DNA或RNA。”

The sensors are printed with a proprietary ink made from graphene – a single layer of carbon atoms used for advanced electronics, energy storage and health-care applications. The sensors are incorporated into a multiplex test cartridge about the size of a cell phone. The cartridges are designed to analyze a variety of sample types, depending on the target.

传感器采用由石墨烯制成的专有墨水印刷而成，石墨烯是一种用于先进电子、能量存储和医疗应用的单层碳原子材料。这些传感器被集成到一个大约手机大小的多重测试卡盒中。这些卡盒旨在根据目标分析各种类型的样本。

Each sensor can be programmed to detect and differentiate multiple pathogens or biomarkers simultaneously using a single half milliliter sample, including blood and saliva specimens..

每个传感器可以使用单个半毫升样本（包括血液和唾液样本）进行编程，以同时检测和区分多种病原体或生物标志物。

The cartridge connects to a reusable Bluetooth reader. The reader transmits results to a mobile app and cloud-based algorithms, which generate final test results. Users are informed by text message in minutes.

药盒连接到一个可重复使用的蓝牙读取器。读取器将结果传输到移动应用程序和基于云的算法，这些算法生成最终测试结果。用户会在几分钟内通过短信收到通知。

IdentifySensors has started manufacturing and intends to make its first FDA submission later this year. The company's three-year plan includes rapid molecular tests for many common diseases and other conditions, such as cancer that can be molecularly detected through genetic sequences.

IdentifySensors已经开始生产，并计划在今年晚些时候进行首次FDA提交。该公司的三年计划包括针对许多常见疾病和其他病症（如可以通过基因序列进行分子检测的癌症）的快速分子测试。

IdentifySensors holds more than 20 patents on the technology and manufacturing processes. The company is currently seeking an additional

识别传感器公司在技术和制造工艺上拥有20多项专利。该公司目前正在寻求额外的

$7.5 million

750万美元

to scale production and develop additional test targets.

扩大生产规模并开发额外的测试目标。

About IdentifySensors Biologics

关于识别传感器生物制品

IdentifySensors Biologics is a nano-bio technology company pioneering a paradigm shift in molecular diagnostics from a hardware heavy, laboratory-based delivery model to a low-cost, portable software-based delivery platform. The transition leverages advancements in nanomaterial-based semiconductors, bioinformatics and AI.

IdentifySensors生物技术公司是一家纳米生物技术公司，引领分子诊断从以硬件为主、基于实验室的交付模式向低成本、便携式基于软件的交付平台的范式转变。这一转型利用了基于纳米材料的半导体、生物信息学和人工智能的进步。

For more information visit .

欲了解更多信息，请访问。

www.identifysensors.com

News Media Contact

新闻媒体联系人

Joe Mosbrook

乔·莫斯布鲁克

mosbrook@acclaimllc.com

莫斯布鲁克@阿克莱姆有限责任公司.com

216-375-2141

SOURCE IdentifySensors Biologics